G1 Therapeutics Inc. (GTHX)
NASDAQ: GTHX
· Real-Time Price · USD
7.16
0.01 (0.14%)
At close: Sep 17, 2024, 9:56 PM
G1 Therapeutics Revenue
G1 Therapeutics reported an annual revenue of $82.51M, reflecting a 60.84% growth. For the quarter ending June 30, 2024, G1 Therapeutics generated $16.55M in revenue.
Revenue (ttm)
82.51M
Revenue Growth
60.84%
Price / Sales Ratio
1.91
Revenue / Employee
825.11K
Employees
100
Market Cap
377.75M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
Dec 31, 2023 | 82.51M | +60.84% |
Dec 31, 2022 | 51.3M | +62.98% |
Dec 31, 2021 | 31.48M | -30.49% |
Dec 31, 2020 | 45.28M | +Infinity% |
Dec 31, 2019 | 0 | n/a |
Dec 31, 2018 | 0 | n/a |
Dec 31, 2017 | 0 | n/a |
Dec 31, 2016 | 0 | -100.00% |
Dec 31, 2015 | 522K | -49.94% |
Dec 31, 2014 | 1.04M | n/a |